The Paternal Clock Nobody Told You About
SaveFertility clinics spend most of their diagnostic attention on the female partner's age because the decline there is steep and well-mapped. The male side gets less airtime — not because age is irrelevant, but because smoking, cannabis, and fixable conditions like varicocele matter more to the numbers.
Last updated: July 2026
Does a Man's Age Affect Fertility?
Reproductive medicine's clearest age-related clock belongs to the female partner: fecundity declines gradually from around 32 and more steeply after 37, which is why evaluation timelines are typically set around her age 1Ref 1American College of Obstetricians and Gynecologists (2025).Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22).Contrasts the well-documented, age-related female fecundity decline (gradual from about 32, steeper after 37) against the comparatively thin evidence base for a paternal-age effect, and grounds the evaluation-timing framing.. The paternal side lacks an equivalent, well-charted curve in major guidance. That does not mean male age is irrelevant — it means what clinicians actually screen for in men looks less like a birthday and more like a checklist of treatable causes.
The question tends to surface after a couple has been trying for a while and starts hunting for explanations. Age is an easy one to reach for, mostly because it is so central to the female half of the conversation. Most of what is well studied about paternal age looks at specific cohorts and specific sperm parameters, and even there, the evidence available does not resolve into one number to fear. What is well established is what to actually do about male fertility once a couple starts asking questions, and that list is concrete and mostly unrelated to age.
What Matters More Than Age for Male Fertility?
Smoking and marijuana use affect male fertility more predictably than the passage of years does. Reproductive medicine's professional guidance finds that men who smoke often need more fertility medication when a couple pursues assisted reproduction, and that both tobacco and marijuana use are tied to lower success with fertility treatment and a higher risk of early pregnancy loss 2Ref 2Practice Committee of ASRM (2024).Tobacco or marijuana use and infertility: a committee opinion.Supports that smoking and marijuana use are linked to needing more fertility medication, reduced ART success, and higher pregnancy-loss risk — modifiable factors that affect male fertility more predictably than age..
These are modifiable exposures, which is the encouraging part — unlike an age-related change, this is something a person can act on directly. Many people find that addressing smoking or cannabis use before starting treatment gives a couple a head start, since both are tied to needing more medication and to lower odds of success once treatment is underway 2Ref 2Practice Committee of ASRM (2024).Tobacco or marijuana use and infertility: a committee opinion.Supports that smoking and marijuana use are linked to needing more fertility medication, reduced ART success, and higher pregnancy-loss risk — modifiable factors that affect male fertility more predictably than age.. A semen analysis, not a birth certificate, is where a male fertility workup actually starts. A normal result at any age points investigation toward the female partner or toward unexplained causes, while an abnormal one opens a specific, treatable path.
What Does a Semen Analysis Actually Check?
A semen analysis checks sperm count, motility (how well the sperm move), and morphology (their shape), along with volume and how quickly the sample liquefies. It is the single test that matters most in a male fertility workup, because it can come back abnormal at any age and normal at any age — there is no age-based reference range the way there is for a woman's ovarian reserve testing.
It's also common for a clinician to request a second sample before drawing firm conclusions from one result, since counts and motility vary naturally from one collection to the next. A single low reading is a reason to retest, not a diagnosis on its own. Because results can also vary by lab technique, many clinicians prefer a sample processed by a lab that specializes in fertility testing over a general hospital lab.
What Happens When a Male-Factor Cause Is Identified?
When testing turns up a specific male-factor cause — low sperm count, poor motility, a varicocele, or a hormonal imbalance — treatment is usually directed at that cause rather than at age itself. Options range from correcting a varicocele surgically to hormonal treatment to moving directly to IUI, IVF, or IVF paired with intracytoplasmic sperm injection, known as ICSI, in which a single sperm is injected directly into an egg; for men with no sperm in the ejaculate, sperm can sometimes be retrieved surgically and combined with ICSI 3Ref 3American Urological Association / American Society for Reproductive Medicine (2020).Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II.Supports the treatment options available once a male-factor cause is identified: varicocele repair, hormonal treatment, IUI/IVF, ICSI, and surgical sperm retrieval for azoospermia..
ICSI is not an automatic upgrade for every egg in every cycle, though. Current guidance from reproductive medicine's professional bodies finds that routinely applying ICSI to every retrieved egg does not raise live-birth rates when there is no male-factor diagnosis or history of failed fertilization. It is a targeted tool for a specific problem, not a general performance boost 4Ref 4Practice Committees of ASRM and SART (2026).Intracytoplasmic sperm injection for nonmale factor indications: a committee opinion.Supports that routine ICSI on all eggs does not raise live-birth rates absent a male-factor diagnosis or prior fertilization failure — it is a targeted tool, not a general upgrade..
When Should a Couple Be Evaluated Together?
Guidelines recommend a couple begin a fertility evaluation after 12 months of regular, unprotected intercourse without a pregnancy if the female partner is under 35, and after 6 months if she is 35 or older 5Ref 5Practice Committee of ASRM (2023).Definition of infertility: a committee opinion.Supports the recommended evaluation timeline (12 months if the female partner is under 35, 6 months if 35 or older) and that a standard workup evaluates both partners from the outset.. That timeline is built around her egg supply, but a standard workup checks both partners from the first visit rather than waiting to see whether testing on one side turns up an explanation.
Waiting for one partner's results before testing the other only delays a diagnosis that a semen analysis can often reach in a single visit. Male-factor causes are common enough that most fertility programs treat concurrent testing as routine, not as a fallback reserved for when the female workup comes back clear.
How Does This Compare With the Female Age Effect?
The most consequential age effect in fertility remains hers, not his. Fecundity declines gradually from around 32 and drops more steeply after 37 — the shape of how age affects female fertility, tracked closely enough that it reshapes when couples are advised to seek help 1Ref 1American College of Obstetricians and Gynecologists (2025).Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22).Contrasts the well-documented, age-related female fecundity decline (gradual from about 32, steeper after 37) against the comparatively thin evidence base for a paternal-age effect, and grounds the evaluation-timing framing..
An AMH by age chart or an antral follicle count can put a number on where a given woman sits on that curve, and egg quality vs quantity explains why a good ovarian reserve number does not guarantee good egg quality. Couples weighing egg freezing age math or comparing age-stratified success rates are, in effect, reading the female half of this story in far more detail than the male side currently supports. None of that changes the practical point for men: time to conception slows for both partners as they age, but the data clinicians actually act on for the male partner is about treatable causes, not the calendar.
Common questions
Related
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When to See a Doctor Sooner
- —Testicular pain, swelling, or a new lump
- —A history of undescended testicle, testicular surgery, or prior chemotherapy or radiation
- —Signs alongside the fertility concern that suggest low testosterone, such as reduced libido, erectile difficulty, or loss of body hair
- —No sperm found on more than one semen analysis
This article is educational and does not replace an evaluation by a fertility specialist, urologist, or reproductive endocrinologist.
References
- 1.American College of Obstetricians and Gynecologists (2025). Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22). American College of Obstetricians and Gynecologists (Obstetrics & Gynecology). link ✓Contrasts the well-documented, age-related female fecundity decline (gradual from about 32, steeper after 37) against the comparatively thin evidence base for a paternal-age effect, and grounds the evaluation-timing framing.
- 2.Practice Committee of ASRM (2024). Tobacco or marijuana use and infertility: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). PMID 38284953 ✓Supports that smoking and marijuana use are linked to needing more fertility medication, reduced ART success, and higher pregnancy-loss risk — modifiable factors that affect male fertility more predictably than age.
- 3.American Urological Association / American Society for Reproductive Medicine (2020). Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II. AUA/ASRM (Fertility and Sterility; Journal of Urology). linkSupports the treatment options available once a male-factor cause is identified: varicocele repair, hormonal treatment, IUI/IVF, ICSI, and surgical sperm retrieval for azoospermia.
- 4.Practice Committees of ASRM and SART (2026). Intracytoplasmic sperm injection for nonmale factor indications: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkSupports that routine ICSI on all eggs does not raise live-birth rates absent a male-factor diagnosis or prior fertilization failure — it is a targeted tool, not a general upgrade.
- 5.Practice Committee of ASRM (2023). Definition of infertility: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkSupports the recommended evaluation timeline (12 months if the female partner is under 35, 6 months if 35 or older) and that a standard workup evaluates both partners from the outset.
5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy